David Delucia serves as Executive at FIBROGEN INC, where they oversee executive responsibilities. Since joining the company, David Delucia has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 3, 2026 involved receiving (via award) 26,000 shares valued at $0.
David Delucia currently holds 26,000 shares of FIBROGEN INC (FGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Delucia has been a net neutral trader of FGEN stock. They have purchased $0 and sold $0 worth of shares.
David Delucia's most recent insider trade was on Feb 3, 2026, when they sold 26,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $8.42 |
| Discretionary |
| Sep 6, 2025 | FGEN | $641 | Payment | 53 | $12.10 | Discretionary |
| Jun 6, 2025 | FGEN | $399 | Payment | 51 | $7.83 | Discretionary |